# Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic

> **NCT04933981** · — · COMPLETED · sponsor: **University of Cologne** · enrollment: 1587 (actual)

## Conditions studied

- COVID-19 Respiratory Infection
- SARS-CoV-2 Infection

## Interventions

- **DIAGNOSTIC_TEST:** Nasopharyngeal swab for SARS-CoV-2

## Key facts

- **NCT ID:** NCT04933981
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-15
- **Primary completion:** 2020-12-15
- **Final completion:** 2021-06-30
- **Target enrollment:** 1587 (ACTUAL)
- **Last updated:** 2024-04-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04933981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04933981, "Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04933981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*